CONMED Corporation Announces Fourth Quarter and Full-Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Conmed (CNMD) Tops Q4 EPS by 1c
January 26, 2022 4:24 PM ESTConmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees... More



